Edition:
United Kingdom

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

0.92USD
23 Apr 2019
Change (% chg)

$-0.02 (-2.11%)
Prev Close
$0.94
Open
$0.93
Day's High
$0.96
Day's Low
$0.90
Volume
917,070
Avg. Vol
1,063,914
52-wk High
$3.58
52-wk Low
$0.50

About

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI)... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $151.58
Shares Outstanding(Mil.): 160.74
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 110.59 62.94
EPS (TTM): -0.05 -- --
ROI: -38.21 8.01 11.75
ROE: -- 8.19 12.58

BRIEF-Aveo Pharmaceuticals Says Co Entered Agreement With Novartis International Pharmaceutical Regarding Aveo's AV380 Program

* AVEO PHARMACEUTICALS INC - ON DEC. 18, AVEO ENTERED AGREEMENT WITH NOVARTIS INTERNATIONAL PHARMACEUTICAL REGARDING AVEO’S AV380 PROGRAM

19 Dec 2018

Earnings vs. Estimates